Research location
Torrevieja
Alicante, Spain
Advertisement
Research activity in Torrevieja
Alicante, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 17 trials and 18 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Torrevieja
17 linked trials · page 1 of 1Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesNCT04435990 · 2020-10-06 · 1 site observation
RECRUITING
Compression Therapy of the Lower Limbs in Patients With Decompensated Heart FailureNCT06418932 · 2024-05-27 · 1 site observation
COMPLETED
Improvement of a Digital Health Platform for Remote Monitoring of Patients With Heart FailureNCT05708846 · 2023-05-18 · 1 site observation
COMPLETED
Anti-SARS-COV2 Vaccination Study in Lung Cancer PatientsNCT05009030 · 2021-05-06 · 1 site observation
COMPLETED
LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)NCT04344002 · 2020-04-21 · 1 site observation
COMPLETED
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung CarcinomaNCT03156868 · 2016-08-03 · 1 site observation
COMPLETED
Study to Evaluate the Effect of a Vegetal Oil on Cognitive ImpairmentNCT02778581 · 2016-03-01 · 1 site observation
UNKNOWN
SYL040012, Treatment for Open Angle GlaucomaNCT02250612 · 2014-10-01 · 1 site observation
COMPLETED
PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast CancerNCT01973660 · 2013-10-01 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateNCT01399697 · 2011-09-01 · 1 site observation
COMPLETED
A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)NCT01064037 · 2010-04-01 · 1 site observation
TERMINATED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease InhibitorNCT01166477 · 2010-01-01 · 1 site observation
COMPLETED
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast CancerNCT00878709 · 2009-07-09 · 1 site observation
COMPLETED
The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic PatientsNCT01510509 · 2009-01-01 · 1 site observation
UNKNOWN
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs AnastrozoleNCT00543127 · 2007-11-01 · 2 site observations
TERMINATED
Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFRNCT00446225 · 2007-02-15 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.